Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Flavonoid glycoside found in Scutellaria.
Oxazolidinone; protein synthesis inhibitor.
Endogenous peptide neurotransmitter, involved i...
Synthetic peptide, vasopressin analog; AVPR1 ag...
Multikinase inhibitor.
PI3K inhibitor, microtubule polymerization inhi...
Minor kavalactone originally found in Piper met...
FIASMA, SERT inhibitor, 5-HT and σ1 antagonist...
Survivin inhibitor.
ROCK1/2 inhibitor.
Vitamin B1
Endogenous peptide hormone, involved in feeding...
Macrolide originally produced by Streptomyces; ...
Isothiocyanate found in cruciferous vegetables,...
DAT inhibitor.
Fluoroquinolone; topoisomerase IV and bacterial...
Sulfonylurea; SUR1 antagonist.
Dual RAF/EGFR inhibitor.
Thrombin inhibitor.
A probe for cholesterol in biological membranes...